DIFFERENTIATED APPROACHES TO TERGETED INTERFERON AND IMMUNOTHERAPY OF ATYPICAL CHRONIC ACTIVE INFECTION CAUSED BY EPSTEIN-BARR VIRUS
The problem of effective therapy of atypical chronic active EBV infection associated with chronic fatigue syndrome (AHA-VEBI) is extremely relevant at the present time. The study revealed the features of the defective functioning of the system of antiviral immune protection, as well as violations in the interferon system in patients suff ering from AHA-WEBI. The main clinical syndromes associated with AHA-WEBI were determined, immunopathogenetic features were clarified, the disease arose and progressed against the background, algorithms of complex diagnostics, including immunodiagnosis, and therapy were developed. The concept of diff erentiated, complex, etio- and immunopathogenetic therapy was developed and tested.